about
Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysisSelective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifeneEfficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis: A Meta-AnalysisAdiponectin as a biomarker of osteoporosis in postmenopausal women: controversiesThe evolution of selective estrogen receptor modulators in osteoporosis therapyVitamin K₂ therapy for postmenopausal osteoporosisThe discovery and development of selective estrogen receptor modulators (SERMs) for clinical practicePINP as a biological response marker during teriparatide treatment for osteoporosisImmune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspectiveDenosumab: mechanism of action and clinical outcomesModulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal OsteoporosisEffect of whole-body vibration on reduction of bone loss and fall prevention in postmenopausal women: a meta-analysis and systematic reviewOxidative Stress-Related Biomarkers in Postmenopausal Osteoporosis: A Systematic Review and Meta-AnalysesAcute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case reportThe epidemiology and management of postmenopausal osteoporosis: a viewpoint from BrazilUpdate on bazedoxifene: a novel selective estrogen receptor modulatorThe association between compliance and persistence with bisphosphonate therapy and fracture risk: a reviewAntiresorptive drugs beyond bisphosphonates and selective oestrogen receptor modulators for the management of postmenopausal osteoporosisBone-Protective Effects of Dried Plum in Postmenopausal Women: Efficacy and Possible Mechanisms.Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis: A meta-analysis of randomized controlled trials.The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal womenEvidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone ClubUpdated clinical recommendations for the use of tibolone in Asian womenAdverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia).Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacyEfficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosisIncorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan.Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.Efficacy and safety of monthly 150 mg oral ibandronate in women with postmenopausal osteoporosis: a systematic review and meta-analysis of randomized controlled trialsThe transforming growth factor-β1 (TGF-β1) gene polymorphisms (TGF-β1 T869C and TGF-β1 T29C) and susceptibility to postmenopausal osteoporosis: a meta-analysis.The ovariectomized rat as a model for studying alveolar bone loss in postmenopausal women.Potential role of odanacatib in the treatment of osteoporosis.Raloxifene for older women: a review of the literatureTransdermal hormone therapy and bone health.Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis.Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice.Postmenopausal osteoporosis: the role of immune system cellsComparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal womenPatient preference in the management of postmenopausal osteoporosis with bisphosphonates.
P921
Q24548778-1987987F-3525-4FD6-854A-B680FC1A5439Q24652524-E7D8239E-E115-4638-A859-78218637E839Q26778216-468C898D-C030-4007-9C53-3E6312D5C4A5Q26825255-8A790EF4-87A1-4818-9E5C-9852CEE57AF4Q26827973-D5BB5092-5873-4883-A950-4C46DD19B68AQ26828372-72841965-C1E6-4D61-B970-FF47C348B6C0Q26830744-82EB16FD-59E2-426B-A3F4-F61CCC4FD1DCQ26859267-31F2CECF-FBE1-4D37-BB3A-7E9214046317Q26991927-64008E3D-74EF-4103-B73C-F0641EE094CAQ27015899-64F1D366-FFE3-489C-A27A-5753E46F2FA0Q27022580-557C9E38-E273-4E5A-902F-B07721608AABQ28073756-D77C47A7-F313-49E3-B772-91E90E15E7B7Q28079397-04ABDBF4-8CBC-4F74-A5F9-B49FD7420012Q28079912-96854176-2384-4D43-96E2-58E315E3AF25Q28080673-B7DCC9A1-FEF0-4DE3-8D0A-22301CC52628Q28258998-A98541E1-AD14-4924-9017-95244C28E86CQ33300458-A5C18F99-40BB-46E5-8C19-C90275071E7CQ33663460-8CBCE82D-D4F2-4D74-BBFF-80AE2EF28C16Q33749496-F2F583C1-EF25-4F8D-B564-303C13C5C50DQ33760576-C8CA5D82-64F1-45A3-B4A5-DBE9B24B6813Q34029509-AF74AC7F-3C4C-4C77-A965-0A7124195D64Q34099162-AFF3772F-C7A8-459E-A034-B19F30CD1889Q34142418-548E5FF0-5327-4ECB-BA7C-F6903C88550DQ34189582-F7AC813F-C57D-4189-8A06-3D81A04CB922Q34482507-311C25D4-DBAB-4617-8AE7-A7FA845D1F98Q34585494-FA14175C-DBD8-4048-B110-0E2509ED5F44Q34658660-C47A2938-9604-4359-9B3F-00C8942F5F2AQ35092609-F06C4715-396C-45D6-98E4-B0E370AD6A44Q35092811-810024B1-DED9-4C32-A3F6-6AB1D6913DFDQ35331699-9A38C0E0-A7D3-4CEA-872B-04C59CCDA79CQ35551513-16AE32E6-7163-4D7F-BF91-1C50BC674A81Q35594595-195A5B3E-EAE5-4205-A899-958F502F7CE5Q36136239-A1724563-D5EB-4F42-8820-C4B1BB7EAAF5Q36892891-A4EC6A51-3685-4736-BAD0-ED3CC4B10D19Q36892895-A3EB2BEF-F8B7-4647-A920-7DCC70D26464Q36897425-0C949CDA-6D3B-422E-96A9-E53C4FC62714Q36897441-CD3ECABA-34B7-4F01-B2C9-1B49A65A67F8Q36914237-6B6464EB-E8D6-4D99-86A4-66288CE90C82Q37018947-939C7318-0FD8-4F15-B62C-1A9CEE2E77ABQ37018957-E3E912CC-9D14-4272-B942-2A5087759E74
P921
description
human disease
@en
name
ostéoporose post-ménopausique
@fr
postmenopausal osteoporose
@nn
postmenopausal osteoporosis
@en
type
label
ostéoporose post-ménopausique
@fr
postmenopausal osteoporose
@nn
postmenopausal osteoporosis
@en
altLabel
Bone Mineral Density Quantitative Trait Locus
@en
Osteoporosis, Postmenopausal
@en
postmenopausal beinskøyrheit
@nn
prefLabel
ostéoporose post-ménopausique
@fr
postmenopausal osteoporose
@nn
postmenopausal osteoporosis
@en
P2176
P2892
P486
P279
P2892
P31
P486
P492
P5270
MONDO:0008159
P672
C05.116.198.579.610
C18.452.104.579.610